- Filed
- Sep 21, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Sep 21, 2020 | 69.97M sh |
| Cash And Equivalents | Q3 2020 · Jul 31, 2020 | $14.47K |
| Cash And Equivalents | Q3 2020 · Oct 31, 2019 | $5.59K |
| Current Liabilities | Q3 2020 · Jul 31, 2020 | $7.26M |
| Current Liabilities | Q3 2020 · Oct 31, 2019 | $6.7M |
| Current Assets | Q3 2020 · Jul 31, 2020 | $129.55K |
| Current Assets | Q3 2020 · Oct 31, 2019 | $119.47K |
| Total Assets | Q3 2020 · Jul 31, 2020 | $281.64K |
| Total Assets | Q3 2020 · Oct 31, 2019 | $218.5K |
| Net Income | Q3 2020 · Jan 31, 2020 | −$63.79K |
| Net Income | Q3 2020 · Jul 31, 2019 | −$212.88K |
| Net Income | Q3 2020 · Jul 31, 2019 | −$701.08K |
| Net Income restated | Q3 2020 · Apr 30, 2019 | −$252.52K |
| Net Income | Q3 2020 · Jan 31, 2019 | −$252.52K |
| Stockholders Equity | Q3 2020 · Nov 2, 2019 | −$6.48M |
| Stockholders Equity | Q3 2020 · Jul 31, 2019 | −$6.37M |
| Stockholders Equity | Q3 2020 · Apr 30, 2019 | −$6.28M |
| Stockholders Equity | Q3 2020 · Jan 31, 2019 | −$6.08M |
| Stockholders Equity | Q3 2020 · Oct 31, 2018 | −$5.62M |
| Shares Diluted | Q3 2020 · Jul 31, 2019 | 69.62M sh |
| Shares Diluted | Q3 2020 · Jul 31, 2019 | 69.62M sh |
| Capex | Q3 2020 · Jul 31, 2019 | $12.44K |
| Operating Cash Flow | Q3 2020 · Jul 31, 2019 | −$550.04K |
| Sga Expense | Q3 2020 · Jul 31, 2019 | $71.13K |
| Sga Expense | Q3 2020 · Jul 31, 2019 | $346.53K |
| Rd Expense | Q3 2020 · Jul 31, 2019 | $48.08K |
| Rd Expense | Q3 2020 · Jul 31, 2019 | $81.1K |
| Operating Income | Q3 2020 · Jul 31, 2019 | −$125.43K |
| Operating Income | Q3 2020 · Jul 31, 2019 | −$443.87K |